Airain Ltd’s AstraZeneca AZN Stock Holding History

Airain Ltd’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,545	Closed	-$369K	–	652
2016 Q1	$369K	Buy	6,545 +2,427	+59%	+$146K	0.03%	517
2015 Q4	$280K	Buy	+4,118	New	+$270K	0.02%	627

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Airain Ltd's AZN Position: Q2 2016 in Review

Airain Ltd sold out of AstraZeneca (AZN) in Q2 2016, closing a stake of 6,545 shares — an estimated $369K sold.

Airain Ltd first reported a position in AZN in Q4 2015 and held it in 2 quarters. The position peaked at $369K in Q1 2016. 398 funds tracked by Wall St. Rank hold AZN as of Q2 2016.

Airain Ltd reported no remaining AstraZeneca position as of Q2 2016 after selling out during the quarter.
Airain Ltd sold 6,545 AstraZeneca shares in Q2 2016, an estimated $369K.
Airain Ltd first reported a position in AstraZeneca in Q4 2015 and held it in 2 quarters.
Airain Ltd's AstraZeneca position peaked at $369K in Q1 2016.
398 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2016.

Based on Airain Ltd's 13F filing for Q2 2016, filed 5 Aug 2016.